The Management of Dermal Filler Complications

ABSTRACT

Injectable fillers have gained widespread acceptance among the public and provide a nonsurgical means of rejuvenating the face. As the demand for fillers increases, facial plastic surgeons must become not only expert injectors but also experts in managing the complications of fillers. Little scientific data exists regarding the incidence of complications, and more adverse effects may be seen with longer-term follow-up of patients. The purpose of this article is to review the most commonly encountered complications and management thereof.

KEYWORDS

Filler complications - granuloma - necrosis

REFERENCES

• 1 Food and Drug Administration Center for Devises and Radiological Health .Executive Summary Dermal Filler Devices. Rockville, MD; U.S. FDA November 18, 2008
• 2 Lemperle G. Treatment options for dermal filler complications.  Aesthet Surg J. 2006;  26 356-364
• 3 Goldman M P, Alster T S, Weiss R. A randomized trial to determine the influence of laser therapy, monopolar radiofrequency treatment an intense pulsed light therapy administered immediately after hyaluronic acid gel implantation.  Dermatol Surg. 2007;  33 535-542
• 4 Bellman B. Complication following suspected intra-arterial injection of Restylane.  Aesthet Surg J. 2006;  26 304-305
• 5 Alam M, Dover J S. Management of complications and sequelae with termporary injectable fillers.  Plast Reconstr Surg. 2007;  120(6S) 98S-105S
• 6 Carruthers J DA, Glogau R G, Blitzer A. and the Facial Aesthetic Consensus Group Faculty . Advances in facial rejuvenation: botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies- concensus recommendations.  Plast Reconstr Surg. 2008;  121(5S) 5S-30S
• 7 Homicz M R, Watson D. Review of injectable materials for soft tissue augmentation.  Facial Plast Surg. 2004;  20 21-29
• 8 Lemperle G, Rullan P P, Gauthier-Hazan N. Avoiding and treating dermal filler complications.  Plast Reconstr Surg. 2006;  118(3S) 92S-107S